Mr. Speaker, of course, we share the member's objective to reduce drug prices for Canadians and to make sure that we have a competitive and fair environment in Canada. We are working together on pharmacare legislation. I look forward to continuing those conversations.
Of course, Canada, by engaging in bulk purchasing, has seen a reduction of about $300 million in the cost of drugs for Canadians across the country. With many countries looking at how they can emulate that kind of practice to reduce drug prices in their countries, we are going to continue to do everything we can.